Research Reports

Key takeaways

Srini Tenjarla, Ph.D., promoted to Chief Technology Officer of Serina (AL), Inc. from Senior Vice President of CMC and Formulation, effective April 20, 2026.

Dr. Tenjarla's annual base salary increased to $425,000, effective back to March 15, 2026.

Steve Ledger's CEO annual base salary increased to $500,000 pursuant to employment agreement, effective September 9, 2024, with retroactive lump sum paid in April 2026.

Board approved amended and restated bylaws effective April 15, 2026, adding provisions for Co-Chairs of the Board including authority to call special meetings and preside over meetings.

Bylaws include conforming updates and corrections; full text filed as Exhibit 3.1.

Full analysis

The promotion of Srini Tenjarla to CTO of the wholly-owned subsidiary Serina (AL), Inc. reflects internal advancement in key technical leadership, with his prior role in CMC and Formulation since July 2024 providing continuity. The significant salary increase to $425,000 underscores the importance of this position. Similarly, the CEO base salary adjustment to $500,000, tied to achieved strategic goals, signals performance-based incentives and retention of top executive talent. The amended bylaws introduce formal provisions for Co-Chairs, enhancing board flexibility by granting them equivalent authority to the Chair for calling meetings and presiding, which may support evolving governance needs. These changes collectively strengthen leadership structure and compensation alignment without altering core operations.

SER · Serina Therapeutics, Inc.

Summary

Key takeaways

Full analysis